BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14746878)

  • 1. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease.
    Scassellati C; Zanardini R; Squitti R; Bocchio-Chiavetto L; Bonvicini C; Binetti G; Zanetti O; Cassetta E; Gennarelli M
    Neurosci Lett; 2004 Feb; 356(2):119-22. PubMed ID: 14746878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
    Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.
    Lio D; Licastro F; Scola L; Chiappelli M; Grimaldi LM; Crivello A; Colonna-Romano G; Candore G; Franceschi C; Caruso C
    Genes Immun; 2003 Apr; 4(3):234-8. PubMed ID: 12700599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
    Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.
    Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z
    Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease.
    Bhojak TJ; DeKosky ST; Ganguli M; Kamboh MI
    Neurosci Lett; 2000 Jul; 288(1):21-4. PubMed ID: 10869806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interleukin-10 polymorphisms with risk factors of Alzheimer's disease and other dementias (SADEM study).
    Vargas-Alarcón G; Juárez-Cedillo E; Martínez-Rodríguez N; Fragoso JM; García-Hernández N; Juárez-Cedillo T
    Immunol Lett; 2016 Sep; 177():47-52. PubMed ID: 27474414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
    Xin XY; Ding JQ; Chen SD
    J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients.
    Seripa D; Matera MG; Dal Forno G; Gravina C; Masullo C; Daniele A; Binetti G; Bonvicini C; Squitti R; Palermo MT; Davis DG; Antuono P; Wekstein DR; Dobrina A; Gennarelli M; Fazio VM
    Neurobiol Aging; 2005 Apr; 26(4):455-64. PubMed ID: 15653174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease.
    Ramos EM; Lin MT; Larson EB; Maezawa I; Tseng LH; Edwards KL; Schellenberg GD; Hansen JA; Kukull WA; Jin LW
    Arch Neurol; 2006 Aug; 63(8):1165-9. PubMed ID: 16908746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.
    Tsai SJ; Hong CJ; Liu HC; Liu TY; Liou YJ
    Dement Geriatr Cogn Disord; 2006; 21(3):139-43. PubMed ID: 16391475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
    Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
    Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOE epsilon 4 carriers.
    Wang M; Jia J
    Neurosci Lett; 2010 Oct; 482(3):260-3. PubMed ID: 20667498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers.
    Matsubara-Tsutsui M; Yamagata H; Morishima A; Nakura J; Mitsuda N; Kamino K; Kondo I; Miki T
    Intern Med; 2002 Oct; 41(10):823-8. PubMed ID: 12413003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.